Benzinga · Mar 10, 2026
Cosmos Health Enters Into LOI To Acquire Extensive Pharmacy Distribution Network, Terms Not Disclosed; Remains On Track To Deliver 2027 Revenue Guidance Of $155.8M
Cosmos Health Inc.
CO
NASDAQ · COSM
Cosmos Health Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$0.21
Up+$0.00 (+0.80%)
Updated Aug 21, 2026, 6:36 PM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 12.05M
- P/E ratio
- -0.73
- Dividend yield
- 0.00%
- 52-week range
- $0.16 – $0.45
- Volume
- 4.2M
- Avg. volume
- 849.47K
Price performance
COSM price history
1M range · 21 trading sessions · Daily adjusted prices
COSM closed at $0.21 after 21 trading sessions, up 6.41% for the selected period.
- Last close
- $0.21
- Period change
- +6.41%
- Period low
- $0.18
- Period high
- $0.24
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 20, 2026 | $0.1917 | $0.2249 | $0.1917 | $0.2126 | 4.2M |
| Aug 19, 2026 | $0.195 | $0.197 | $0.1781 | $0.193 | 4.69M |
| Aug 18, 2026 | $0.2049 | $0.2142 | $0.2008 | $0.2066 | 2.72M |
| Aug 17, 2026 | $0.22 | $0.224 | $0.205 | $0.205 | 1.64M |
| Aug 14, 2026 | $0.2076 | $0.2179 | $0.2053 | $0.2179 | 953.97K |
| Aug 13, 2026 | $0.2055 | $0.2105 | $0.2039 | $0.2065 | 1.41M |
| Aug 12, 2026 | $0.2164 | $0.22 | $0.205 | $0.2071 | 1.96M |
| Aug 11, 2026 | $0.2217 | $0.23 | $0.212 | $0.2198 | 1.89M |
| Aug 10, 2026 | $0.2321 | $0.25 | $0.2209 | $0.2235 | 3.86M |
| Aug 7, 2026 | $0.25 | $0.25 | $0.23 | $0.233 | 5.74M |
| Aug 6, 2026 | $0.2151 | $0.227 | $0.207 | $0.221 | 2.62M |
| Aug 5, 2026 | $0.2262 | $0.2297 | $0.2059 | $0.2148 | 1.89M |
| Aug 4, 2026 | $0.2345 | $0.2369 | $0.2186 | $0.224 | 2.43M |
| Aug 3, 2026 | $0.2169 | $0.2418 | $0.2135 | $0.235 | 5.88M |
| Jul 31, 2026 | $0.2001 | $0.2162 | $0.195 | $0.2156 | 5.03M |
| Jul 30, 2026 | $0.1899 | $0.21 | $0.185 | $0.2001 | 5.4M |
| Jul 29, 2026 | $0.192 | $0.1942 | $0.1773 | $0.1827 | 2.88M |
| Jul 28, 2026 | $0.2056 | $0.2056 | $0.1922 | $0.1949 | 2.61M |
| Jul 27, 2026 | $0.1957 | $0.2074 | $0.1936 | $0.2074 | 2.9M |
| Jul 24, 2026 | $0.20 | $0.2148 | $0.1955 | $0.1999 | 4.42M |
| Jul 23, 2026 | $0.2147 | $0.2189 | $0.1971 | $0.1998 | 4.78M |
Latest COSM news
The latest Smart Investors Daily articles mentioning COSM.
Stock researchCompany · Overview
COSM research
Overview
Company profile and research snapshot.
Company profile
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Feb 24, 2026
Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board
CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company’s biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug
Yahoo · Feb 19, 2026
Cosmos Health Highlights Approximately $15 Million Fair Market Value of Real Estate Assets, Exceeding Current Market Capitalization; Evaluates Monetization Options to Address Significant Discount to Book Value
CHICAGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today highlighted the intrinsic value of its wholly owned real estate portfolio and announced that it is evaluating strategic monetization options to unlock shareholder value. Based on independent valuation reports, recent market data, and comparable transactions, management estimates the combined fair market value of the Co
Yahoo · Feb 18, 2026
Cosmos Health Continues UK Retail Expansion for C-Scrub; Now Available at Superdrug, the UK’s Second-Largest Beauty and Health Retailer
CHICAGO, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced continued expansion of its United Kingdom (UK) retail footprint as its antimicrobial skin cleanser, C-Scrub Wash Chlorhexidine 4% (“C-Scrub”), is now available through Superdrug, the UK’s second-largest beauty and health retailer. Established over 60 years ago, Superdrug is widely recognized for its leadershi
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
